Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Merck KGaA and sanofi-aventis to jointly investigate new anticancer agents

Dec. 20, 2010

Jennerex and Transgene begin JX-594 trial in metastatic colorectal cancer

Dec. 17, 2010

Amgen identifies novel inhibitors of PI3K-alpha and/or mTOR

Dec. 17, 2010

Novartis withdraws application to extend Zometa indication in E.U.

Dec. 17, 2010

E.C. approves sunitinib malate for treatment of pancreatic neuroendocrine tumors

Dec. 17, 2010

New diaza heterocyclic agents identified at Mallinckrodt

Dec. 17, 2010

Tivozanib/paclitaxel combination is well tolerated by patients with metastatic breast cancer

Dec. 17, 2010

Selective JAK-2 inhibitor BMS-911543 enters clinic as myelofibrosis therapy

Dec. 17, 2010

Preclinical study in MM shows activity of GNE-652 and synergism with GDC-0941

Dec. 17, 2010

ACY-1215/bortezomib combination shows promise in models of multiple myeloma

Dec. 17, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026